Cost-effectiveness of cervical-cancer screening in five developing countries

Sue J Goldie1, Lynne Gaffikin, Jeremy D Goldhaber-Fiebert

  • 1Department of Health Policy and Management, Harvard School of Public Health, Boston, USA. sue_goldie@harvard.edu

Summary

Single-visit cervical cancer screening using visual inspection or HPV DNA testing is cost-effective in developing countries. These strategies significantly reduce cancer risk with fewer visits compared to traditional methods.